$STOK

$26.35▲ -0.2% YTD

6 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

CP $26.35▲ -0.2%Oct 29, 2026 · ThinkSabio Blog

$STOK reported Q3 2026 EPS of -$1.08, missing the -$0.91 estimate by 18.7%. Revenue of $11.3M beat the $8.2M estimate by 37.2%…

News

STOK ▼ -0.1% - Stoke Therapeutics, Inc.

CP $25.32▲ -0.1%Oct 6, 2026 · ThinkSabio Blog

$STOK Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)…

SEC 13D/G

STOK - Stoke Therapeutics, Inc. - SEC Filing Update (30-SEP-2026) | ThinkSabio - Stocks Simplified

$26.00▼ -15.86%Sep 30, 2026 · ThinkSabio Blog

$STOK SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #STOK Stoke Therapeutics, Inc. : $26.00 Sector: Healthcare | YTD…

News

STOK ▼ -9.4% - Stoke Therapeutics, Inc.

CP $26.49▲ -9.4%Sep 23, 2026 · ThinkSabio Blog

$STOK Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development…

News

STOK ▲ +0.8% - Stoke Therapeutics, Inc.

CP $31.50▲ +0.8%Sep 1, 2026 · ThinkSabio Blog

$STOK Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatmen…

SEC 13D/G

STOK - Stoke Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$32.42▲ 4.92%Aug 6, 2026 · ThinkSabio Blog

$STOK SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #STOK Stoke Therapeutics, Inc. : $32.42 Sector: Healthcare | YTD…